Eikon Therapeutics, Inc. Common Stock (EIKN) Financials
EIKN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 594.7 million | 1.5 billion |
| Sept. 30, 2025 | 642.3 million | 1.4 billion |
| Dec. 31, 2024 | 491.2 million | 1.1 billion |
EIKN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -41.8 million | 3.9 million |
| Sept. 30, 2025 | ? | ? |
| Dec. 31, 2024 | -63.3 million | 3.2 million |
EIKN Net Income
No data available :(
EIKN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | - | - | 257.3 million |
| Sept. 30, 2025 | - | - | 240.7 million |
| Dec. 31, 2024 | - | - | 202.5 million |
EIKN Shares Outstanding
EIKN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 66000 | 65.2 million | 17.9 million | - |
| Sept. 30, 2025 | - | - | - | - |
| Dec. 31, 2024 | 39.5 million | 53.9 million | 13.9 million | - |
EIKN Cost of Revenue
No data available :(
EIKN
Price: $9.61
52 week price:
Earnings Per Share: -6.32 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 26.4 million